Systemic and topical steroids in inflammatory bowel disease
- 3 September 2004
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 20 (s4), 66-74
- https://doi.org/10.1111/j.1365-2036.2004.02059.x
Abstract
Steroids are still widely used in the treatment of inflammatory bowel diseases. Pharmacological studies have shown that there is no major abnormality in the pharmacokinetics of steroids in these disorders. Foam preparations with rectal application decrease the bioavailability to low levels, eliminating systemic complications. For oral use, 'nonsystemic' steroids have been developed. In ulcerative colitis, steroids are rarely needed as 5-aminosalicylates are effective in the majority of patients. This is true for rectal application in distal colitis, as well as in more extensive disease. In Crohn's disease, steroids are more often used; however, in population-based studies, less than 50% of patients have been treated with steroids, as there are alternative treatments available for the large group of patients with mild to moderate activity. For those patients needing steroid treatment, budesonide seems to be a good choice in active disease, but has not shown convincing effects in the maintenance of remission over longer periods of time. There is no place for long-term steroid treatment in ulcerative colitis and very little in Crohn's disease--immunosuppression with azathioprine or related drugs is certainly the better alternative.This publication has 51 references indexed in Scilit:
- Prednisolone absorption in inflammatory bowel disease: correlation with anatomical site and extentAlimentary Pharmacology & Therapeutics, 2007
- Glucocorticoid receptors are down‐regulated in inflamed colonic mucosa but not in peripheral blood mononuclear cells from patients with inflammatory bowel diseaseEuropean Journal of Clinical Investigation, 1999
- Colitis patients not responding to high dose corticosteroids have a low glucocorticoid receptor content of their mononuclear cellsGastroenterology, 1995
- Pharmacokinetics and absolute rectal bioavailability of hydrocortisone acetate in distal colitisAlimentary Pharmacology & Therapeutics, 1992
- Pharmacokinetics and Rectal Bioavailability of Hydrocortisone AcetateJournal of Pharmaceutical Sciences, 1991
- Effect of inflammatory bowel disease on absorption and disposition of prednisoloneDigestive Diseases and Sciences, 1983
- Serum Prednisolone Levels in Crohn’s Disease and Coeliac Disease following Oral Prednisolone AdministrationDigestion, 1981
- Prednisolone absorption in acute colitis.Gut, 1980
- Clinical Pharmacokinetics of Prednisone and PrednisoloneClinical Pharmacokinetics, 1979
- CorticosteroidsDrugs, 1978